Optional Post-conference Opioid REMS Course
Wednesday, December 4, 2018, Encore at Wynn Las Vegas
3:00 pm – 6:15 pm
3 CME Credits Available
Pain Management and Opioids: Balancing Risks and Benefits
The misuse of extended-release and long-acting (ER/LA) opioids is a major public health problem. Centers for Disease Control and Prevention reported the following:
- From 2000 to 2015, more than half a million people died from drug overdoses.
- 91 Americans die every day from an opioid overdose.
The Pain Management and Opioids: Balancing Risks and Benefits course addresses this public health crisis. This comprehensive course was developed by renowned experts from Collaborative for REMS Education (CO*RE) and incorporates all six units outlined in the FDA blueprint for safe opioid prescribing by discussing biopsychosocial aspects of pain, the newest clinical guidelines on the treatment of chronic pain, and state policies about prescribing opioids.
*This course is not intended to advocate for the use of ER/LA opioids, but to ensure proper education about safe prescribing practices should a medical provider determine that ER/LA opioids are the best course of treatment.
Edwin Salsitz, MD
Medical Director, Office-Based Opioid Therapy
Mount Sinai Beth Israel
Assistant Professor of Medicine
Mount Sinai Icahn School of Medicine
New York, New York
3:00 – 6:15 PM
Participants of this course will learn to:
- Accurately assess patients with pain for consideration of an opioid trial.
- Establish realistic goals for pain management and restoration of function.
- Initiate opioid treatment (IR and ER/LA) safely and judiciously, maximizing efficacy while minimizing risks
- Monitor and re-evaluate treatment continuously; discontinue safely when appropriate.
- Counsel patients and caregivers about use, misuse, abuse, diversion, and overdose.
- Educate patients about safe storage and ability to access general and specific information about opioids, especially those used in your practice.
The Risk Evaluation and Mitigation Strategies (Opioid REMS) for Extended-Release, Long-Acting Opioids will offer continuing education (CME/CNE) credit for physicians and nurses. Credit will be awarded for those sessions attended and evaluated. Successful completion requires that participants register for the meeting, attend and participate, and complete an online evaluation and a posttest. Participants will receive their certificates immediately after they submit their evaluations online.
This Live activity, Pain Management and Opioids: Balancing Risks and Benefits, will take place Wednesday, December 4, 2018 in Las Vegas, has been submitted for review to the American Academy of Family Physicians and is acceptable for up to 3.0 Prescribed credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Pain Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Pain Society designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society.
This activity has been submitted to the American Association of Neuroscience Nurses for approval to award contact hours. The American Association of Neuroscience Nurses is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses may receive a maximum of 3.0 contact hours for completing this program.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesics Opioid REMS Program Companies (RPC). Please visit www.er-laopioidREMS.com for a listing of member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesics Opioid REMS education requirements issued by the FDA.